当前位置:首页 - 行情中心 - 海王生物(000078) - 财务分析 - 资产负债表

海王生物

(000078)

  

流通市值:61.72亿  总市值:61.83亿
流通股本:26.26亿   总股本:26.31亿

资产负债表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
流动资产:
货币资金3,275,636,071.843,456,273,633.713,259,217,781.653,995,251,804.18
应收票据及应收账款16,402,665,359.516,219,849,159.8318,045,901,095.7117,868,850,024.36
其中:应收票据1,036,126,120.32900,426,597.571,177,688,206.581,095,641,674.12
应收账款15,366,539,239.1815,319,422,562.2616,868,212,889.1316,773,208,350.24
应收款项融资137,880,269.28164,791,057.77100,199,746.46116,666,932.73
预付款项359,870,313.37317,289,075.05528,388,443.03461,837,707.88
其他应收款合计1,833,551,011.831,822,982,141.211,915,969,707.961,843,107,589.88
应收股利8,613,579.128,613,579.121,602,579.121,602,579.12
存货3,360,548,554.393,486,933,682.123,592,262,508.193,498,242,090.83
一年内到期的非流动资产23,213,869.5523,691,517.585,998,472.28152,247,519.38
其他流动资产240,323,273.64217,579,675.78191,326,509.11186,434,988.93
流动资产平衡项目0000
流动资产合计25,757,120,262.8725,834,823,219.0427,847,481,366.7828,252,921,733.74
非流动资产:
长期应收款--610,798.635,129,060.25
长期股权投资193,571,404.87193,570,097.26186,516,435.38190,305,178.16
其他权益工具投资140,337,205140,337,205163,047,205175,567,760
投资性房地产72,775,911.7875,059,053.0872,770,434.5775,165,499.44
固定资产893,228,184.61951,245,081.84991,158,200.46987,467,300.18
在建工程101,678,874.0184,842,238.4584,452,814.2978,258,194.61
使用权资产139,491,193.03147,984,570.84212,645,658.62194,625,260.34
无形资产328,387,122.23367,599,585.5369,109,496.07373,030,842.27
开发支出105,978,281.29102,657,567.09102,088,398.5399,963,610.24
商誉378,703,201.02378,703,201.02856,486,067.99856,486,067.99
长期待摊费用27,514,330.5929,527,172.126,114,492.3329,369,666.32
递延所得税资产330,748,306.11357,016,449.49285,976,131.42294,705,432.11
其他非流动资产134,441,625.5134,954,723.46120,398,506.7146,679,793.53
非流动资产平衡项目0000
非流动资产合计2,846,855,640.042,963,496,945.133,471,374,639.993,506,753,665.44
资产平衡项目0000
资产总计28,603,975,902.9128,798,320,164.1731,318,856,006.7731,759,675,399.18
流动负债:
短期借款9,929,594,672.2110,023,491,526.110,472,660,484.610,444,657,477.64
交易性金融负债72,709,111.7472,709,111.7481,297,611.7487,680,551.53
应付票据及应付账款9,046,183,034.229,102,899,321.39,778,077,186.9110,038,777,300.38
其中:应付票据1,863,801,115.351,759,604,232.212,276,725,844.232,585,118,792.33
应付账款7,182,381,918.877,343,295,089.097,501,351,342.687,453,658,508.05
预收款项1,497,891.911,272,452.781,940,200.422,306,761.06
合同负债364,629,004.73363,608,592.28438,083,950.18465,757,743.77
应付职工薪酬80,585,616.47124,119,130.9766,399,268.9267,679,470.17
应交税费115,703,700.88116,143,353.78143,445,210.08140,830,879.63
其他应付款合计5,026,329,199.625,095,830,356.065,084,297,200.325,208,529,396.86
应付股利115,531,902.98143,514,334.91130,396,583.77118,819,896.51
一年内到期的非流动负债115,943,509.12221,102,388.47212,057,853.79226,531,081.04
其他流动负债450,009,566.84457,986,589.55413,212,522408,709,441.92
流动负债平衡项目0000
流动负债合计25,203,185,307.7425,579,162,823.0326,691,471,488.9627,091,460,104
非流动负债:
长期借款356,104,246.7229,796,779.81269,448,888.95260,310,555.62
租赁负债93,517,968.7999,886,812.32136,075,709.92125,452,414.14
长期应付款2,546,902.763,514,443.054,615,691.625,547,082.83
长期应付职工薪酬181,968.74181,968.74240,430.3240,430.3
预计负债499,526.8119,542,639.52--
递延收益8,195,75010,191,377.7413,982,544.7714,142,214.01
递延所得税负债10,269,895.5512,279,806.412,530,662.9112,870,383.66
非流动负债平衡项目0000
非流动负债合计471,316,259.35375,393,827.58436,893,928.47418,563,080.56
负债平衡项目0000
负债合计25,674,501,567.0925,954,556,650.6127,128,365,417.4327,510,023,184.56
所有者权益(或股东权益):
实收资本(或股本)2,631,123,2572,631,123,2572,631,123,2572,750,833,257
资本公积2,096,312,097.212,096,302,343.692,074,625,971.342,242,485,823.64
减:库存股---275,118,243.17
其他综合收益-60,303,050.4-60,303,050.4-37,593,050.4-37,593,050.4
盈余公积52,141,669.2252,141,669.2252,141,669.2252,141,669.22
未分配利润-2,900,315,987.92-2,924,031,770.95-1,684,399,489.07-1,685,206,984.02
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计1,818,957,985.111,795,232,448.563,035,898,358.093,047,542,472.27
少数股东权益1,110,516,350.711,048,531,0651,154,592,231.251,202,109,742.35
股东权益平衡项目0000
股东权益合计2,929,474,335.822,843,763,513.564,190,490,589.344,249,652,214.62
负债和股东权益合计28,603,975,902.9128,798,320,164.1731,318,856,006.7731,759,675,399.18
公告日期2025-04-292025-04-292024-10-312024-08-31
审计意见(境内)标准无保留意见
TOP↑